ADVANTAGE 400 SPOT-ON SOLUTION FOR DOGS

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

IMIDACLOPRID

제공처:

Bayer Limited

ATC 코드:

QP53AX17

INN (International Name):

IMIDACLOPRID

복용량:

400 Per Cent

약제 형태:

Spot On Solution

처방전 유형:

POM

치료 그룹:

Canine

치료 영역:

Imidacloprid

치료 징후:

Ectoparasiticide

승인 상태:

Authorised

승인 날짜:

2001-02-23

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 400 Spot-on solution for Dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear yellow to slightly brownish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of flea infestations and for the
treatment of biting lice_ (Trichodectes canis)_ on dogs of
25 kg body weight and greater.
For dogs less than 25 kg body weight, use the appropriate Advantage
for Dogs product (see section 4.9).
Fleas on dogs are killed within one day following treatment. One
treatment prevents further flea infestation for four
weeks.
The product can be used as part of a treatment strategy for the
control of Flea Allergy Dermatitis (FAD) where this has
been previously diagnosed by a veterinary surgeon.
4.3 CONTRAINDICATIONS
Do not treat unweaned puppies of less than 8 weeks of age.
Do not use in animals that are known to be hypersensitive to the
active substance or any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
ACTIVE SUBSTANCE:
QUANTITY:
Imidacloprid
400
mg/pipette
(4.0 ml of a 10 % solution)
EXCIPIENT(S)
Butylhydroxytoluene (E 321)
4.0
mg/pipette
For full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_6_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_1_
_8_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_